Diltiazem Hydrochloride In Sodium Chloride Injection, Solution
Product Images NDC 44567-662

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride In Sodium Chloride (NDC 44567-662). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wg Critical Care, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Image (Image 01)

Chemical structure diagram of diltiazem hydrochloride, showing its molecular components and arrangement.*

FDA Label Image

Diltiazem HCl In 0.72% Sodium Chloride Injection 100 mg Per 100 mL Bag Image (Image 02)

Label for Diltiazem Hydrochloride in 0.72% Sodium Chloride Injection, 1 mg/mL (100 mg per 100 mL) intravenous solution. The package contains 100 mL. Manufactured by WG Critical Care, LLC, Paramus, NJ, made in Switzerland. The label includes instructions for intravenous use, storage conditions, and disposal warnings.*

FDA Label Image

Diltiazem HCl In 0.72% Sodium Chloride Injection 250 mg Per 250 mL Bag Image (Image 03)

Label for Diltiazem Hydrochloride injection in 0.72% Sodium Chloride solution, 250 mg per 250 mL (1 mg per mL) intravenous injection. Manufactured for WG Critical Care, LLC, with storage instructions and warnings for intravenous use only. Made in Switzerland, revision date 02/2025.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.